The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 23, Issue 5, 2003, Pages 811-817

  Ambrogi, Vincenzo ^a   Pompeo, Eugenio ^a   Elia, Stefano ^a   Pistolese, Giuseppe Raimondo ^a   Mineo, Tommaso Claudio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Lung cancer; Surgery; Vascular disease

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTERY DISEASE; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SURGERY; CAROTID ARTERY OBSTRUCTION; COMORBIDITY; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; LEG ARTERY; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; THORAX SURGERY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 0037997885     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(03)00093-9     Document Type: Conference Paper

References (23)

1. Nesbitt J.C., Putnam J.B., Garrett L.W., Roth J.A., Mountain C.F. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg. 60:1995;466-472.
2. Read R.C., Yoder G., Schaeffer R.C. Survival after conservative resection for T1N0M0 non-small cell lung cancer. Ann Thorac Surg. 49:1990;391-400.
3. Pater J.L., Loeb M. Nonanatomic prognostic factors in carcinoma of the lung. Cancer. 50:1982;32631.
4. Piccirillo J.F., Feinstein A.R. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer. 77:1996;834-842.
5. Janssen-Heijnen M.L.G., Schipper R.M., Razenberg P.P.A., Crommelin M.A., Coebergh J.W. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 21:1998;105-113.
6. Beauchamp G., Lassonde J., Laurendeau F., Leveille A. Lung cancer and peripheral vascular surgery. Can J Surg. 26:1983;472-474.
7. Duque J.L., Ramos G., Castrodeza J., Cerezal J., Castanedo M., Yuste M., Heras F. Early complications in surgical treatment of lung cancer: a prospective, multicenter study: Grupo Cooperativo de Carcinoma Broncogenico de la Sociedad Espanola de Neumologia y Cirugia Toracica. Ann Thorac Surg. 63:1997;944-950.
8. Lopez-Encuentra A. Bronchogenic Carcinoma Co-operative Group: Comorbidity in operable lung cancer: a multicenter descriptive study on 2992 patients. Lung Cancer. 35:2002;263-269.
9. Voets A.J., Joesoef K.S., van Teeffelen M.E. Synchroneously occurring lung cancer (stages I-II) and coronary artery disease: concomitant versus staged surgical approach. Eur J Cardiothorac Surg. 12:1997;713-717.
10. Kearney D.J., Lee T.H., Reilly J.J., DeCamp M.M., Sugarbaker D.J. Assessment of operative risk in patients undergoing lung resection. Chest. 105:1994;753-759.
11. Rao V., Todd T.J., Weisel R.D., Komeda M., Cohen G., Ikonomidis J.S., Christakis G.T. Results of combined pulmonary resection and cardiac operation. Ann Thorac Surg. 62:1996;342-347.
12. Mountain C.F. Revisions in the international system for staging lung cancer. Chest. 111:1997;1710-1717.
13. Breyer R.H., Karstaedt N., Mills S.A., Johnston F.R., Choplin R.H., Wolfman N.T., Hudspeth A.S., Cordell A.R. Computed tomography for evaluation of mediastinal lymph nodes in lung cancer: correlation with surgical staging. Ann Thorac Surg. 38:1984;215-220.
14. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedrsen O.F., Peslin R., Yernault J.C. Lung volumes and forced ventilatory flows: Report working party standardization of lung function tests, European Community for Steel and Coal: Official statement of the European Respiratory Society. Eur Respir J. 16:1993;5-40.
15. Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
16. Mantel N. Evaluation of survival data and two new-rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
17. Cox D.R. Regression models and life tables. J R Stat Soc. 34:1972;187-220.
18. Gawenda M., Adili F., Walter M., Erasmi H., Heindel W. The prevalence of lung cancer in vascular surgery patients. Thorac Cardiovasc Surgeon. 44:1996;304-307.
19. Ginsberg R.J., Rubinstein L. Lung Cancer Study Group, Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg. 60:1995;615-623.
20. Korst R.J., Ginsberg R.J. Appropriate surgical treatment of resectable non-small-cell lung cancer. World J Surg. 25:2001;184-188.
21. Romano P.S., Mark D.H. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest. 101:1992;1332-1337.
22. Harpole D.H., Liptay M.J., DeCamp M.M., Mentzer S.J., Swanson S.J., Sugarbaker D.J. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg. 61:1996;977-982.
23. Damhuis R.A.M., Schutte P.R. Resection rates and postoperative mortality in 7899 patients with lung cancer. Eur Respir J. 9:1996;7-10.